真武汤合血府逐瘀汤对慢性心衰患者心功能及心室重构的影响

doi:10.3969/j.issn.1671-7171.2022.09.007

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1135 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the effect of Zhenwu decoction combined with Xuefu Zhuyu decoction on cardiac function and ventricular remodeling in patients with chronic heart failure. 【Methods】A total of 120 patients with chronic heart failure admitted to our hospital from June 2018 to June 2021 were selected and randomly divided into observation group and control group with 60 patients in each group. The control group was treated with conventional western medicine, while the observation group was treated with Zhenwu decoction combined with Xuefu Zhuyu decoction on the basis of the control group. Compare the clinical efficacy of the two groups, record the TCM syndrome scores of the two groups, compare the left ventricular ejection fraction (LVEF), left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), left ventricular end diastolic thickness (PWD), left ventricular myocardial mass index (LVMI), left ventricular posterior wall thickness (LVPWT) of the two groups before and after treatment, and detect the serum aldosterone (ALD) Angiotensin Ⅱ (Ang Ⅱ) level and adverse reactions during treatment were recorded. 【Results】 The total clinical effective rate in the observation group was 88.33% (53/60), higher than that in the control group 75.00% (45/60), with a statistically significant difference (P<0.05). After treatment, the scores of main syndrome and secondary syndrome in the two groups were lower than those before treatment, and the scores in the observation group were lower than those in the control group, with a statistically significant difference (P<0.05); LVESD, LVEDD, PWD, LVMI, LVPWT of the two groups were lower than before treatment, LVEF was higher than before treatment, and the difference between the observation group and the control group was statistically significant (P<0.05); The levels of serum ALD and Ang Ⅱ in the two groups were lower than those before treatment, and those in the observation group were lower than those in the control group, the difference was statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). 【Conclusion】 The Zhenwu decoction combined with the Xuefu Zhuyu decoction is effective in treating patients with chronic heart failure, which is beneficial to improve the clinical symptoms of patients with chest tightness, chest pain, palpitation, and better improve the cardiac function and ventricular remodeling of patients. It is safe and has popularization value.

Key words： Heart Failure/ZY Chronic Disease Heart Function Tests Ventricular Remodeling

Received: 07 February 2022

PACS:

R541.61

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIANG Yue
	FU Xiao-xing

Cite this article:

XIANG Yue,FU Xiao-xing. Effect of Zhenwu Decoction Combined with Xuefu Zhuyu Decoction on Cardiac Function and Ventricular Remodeling in Patients with Chronic Heart Failure[J]. JOURNAL OF CLINICAL RESEARCH, 2022, 39(9): 1303-1306.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2022.09.007 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2022/V39/I9/1303

[1] HEINZEL F R,HEGEMANN N,HOHENDANNER F,et al.Left ventricular dysfunction in heart failure with preserved ejection fraction molecular mechanisms and impact on right ventricular function[J].Cardiovasc Diagn Ther,2020,10(5):1541-1560.
[2] BUDNEVSKY A V,SHURUPOVA A D,KRAVCHENKO A Y,et al.Clinical efficacy of acute respiratory viral infections prevention in patients with chronic heart failure[J].Ter Arkh,2019,91(3):36-41.
[3] FEICKERT S,D'ANCONA G,MURERO M,et al.Intra-cardiac microcomputer allows for innovative telemedicine in chronic heart failure during coronavirus disease-2019 pandemic:a case report[J].Eur Heart J Case Rep,2020,4(6):1-6.
[4] 金蕾,姬琛华,宓丹,等.温阳益心汤治疗慢性心力衰竭临床疗效观察[J].辽宁中医药大学学报,2021,23(2):198-201.
[5] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122.
[6] 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:77-85.
[7] 张沛华,张韵,朱桂芬.血府逐瘀汤联合依那普利对心力衰竭患者血清炎症因子水平的影响[J].山西医药杂志,2020,49(18):2430-2432.
[8] 王希山,晋玉梅,祖建国,等.真武汤合血府逐瘀汤加减治疗冠心病慢性心力衰竭的临床效果观察[J].贵州医药,2021,45(4):608-609.
[9] 王颖,陈虎,吕旺,等.血府逐瘀汤联合西药治疗慢性心力衰竭合并抑郁症血行郁滞证[J].吉林中医药,2020,40(2):201-204.
[10] 张革萍,苗迎春.真武汤加减联合西医常规治疗充血性心力衰竭疗效观察[J].陕西中医,2017,38(7):861-862.
[11] 万嘉洋,杨洁红,虞立,等.甘草次酸、甘草苷配伍次乌头碱对慢性心衰大鼠细胞凋亡通路的影响[J].中成药,2017,39(10):2018-2023.
[12] POLYAKOVA E A,MIKHAYLOV E N,SONIN D L,et al.Neurohumoral,cardiac and inflammatory markers in the evaluation of heart failure severity and progression[J].J Geriatric Cardiol,2021,18(1):47-66.